Scalable manufacturing of clinical‐grade differentiated cardiomyocytes derived from human‐induced pluripotent stem cells for regenerative therapy

Basic research on human pluripotent stem cell (hPSC)‐derived cardiomyocytes (CMs) for cardiac regenerative therapy is one of the most active and complex fields to achieve this alternative to heart transplantation and requires the integration of medicine, science, and engineering. Mortality in patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Morita, Yuika, Kishino, Yoshikazu, Fukuda, Keiichi, Tohyama, Shugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357358/
https://www.ncbi.nlm.nih.gov/pubmed/35534945
http://dx.doi.org/10.1111/cpr.13248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357358/
https://www.ncbi.nlm.nih.gov/pubmed/35534945
http://dx.doi.org/10.1111/cpr.13248

Ejemplares similares